Decreased lymphocyte proliferation is correlated with increased PD-1 and PD-1 ligand expression in septic shock patients

被引：0
|
作者：
Venet, Fabienne
Guignant, Caroline
Lepape, Alain
Ayala, Alfred
Monneret, Guillaume
机构：
来源：
INFLAMMATION RESEARCH | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
A79
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [31] Expression of PD-L1 and PD-1 in conjunctival melanoma
    Cao, Jinfeng
    Richards, Kate
    Jordanova, Ekaterina S.
    Arinkovic, Marina
    Hurkmans, Daan
    van Duinen, Sjoerd G.
    van der Velden, Pieter A.
    Jager, Martine J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [32] PD-1 and PD-L1 expression in ovarian cancer
    Wieser, V.
    Gaugg, I.
    Fleischer, M.
    Reimer, D.
    Zeimet, A.
    Fiegl, H.
    Marth, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [33] Expression of PD-L1 and PD-1 in Cutaneous Warts
    Yu, Wesley
    Berger, Timothy
    Laszik, G. Zoltan
    North, Jeffrey
    Cohen, Jarish
    MODERN PATHOLOGY, 2019, 32
  • [34] A PD-1/PD-L1 Proximity Assay as a Theranostic Marker for PD-1 Blockade in Patients with Metastatic Melanoma
    Girault, Isabelle
    Adam, Julien
    Shen, Shensi
    Roy, Severine
    Brard, Caroline
    Faouzi, Sara
    Routier, Emilie
    Lupu, Jeremy
    Warren, Sarah
    Sorg, Kristina
    Ong, SuFey
    Morel, Pascale
    Scoazec, Jean-Yves
    Vagner, Stephan
    Robert, Caroline
    CLINICAL CANCER RESEARCH, 2022, 28 (03) : 518 - 525
  • [35] Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy
    Bevins, Nicholas J.
    Okamura, Ryosuke
    Montesion, Meagan
    Adashek, Jacob J.
    Goodman, Aaron M.
    Kurzrock, Razelle
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2022, 5 (04) : 90 - 97
  • [36] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
    Bai, Jie
    Gao, Zhitao
    Li, Xiang
    Dong, Liang
    Han, Weidong
    Nie, Jing
    ONCOTARGET, 2017, 8 (66) : 110693 - 110707
  • [37] Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
    Lipson, Evan J.
    Lilo, Mohammed T.
    Ogurtsova, Aleksandra
    Esandrio, Jessica
    Xu, Haiying
    Brothers, Patricia
    Schollenberger, Megan
    Sharfman, William H.
    Taube, Janis M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [38] Prognostic Significance of Programmed Cell Death 1 (PD-1) or PD-1 Ligand 1 (PD-L1) Expression in Epithelial-Originated Cancer A Meta-Analysis
    Zhang, Yaxiong
    Kang, Shiyang
    Shen, Jianfei
    He, Jiaxi
    Jiang, Long
    Wang, Wei
    Guo, Zhihua
    Peng, Guilin
    Chen, Gang
    He, Jianxing
    Liang, Wenhua
    MEDICINE, 2015, 94 (06) : e515
  • [39] PD-1 in RA
    Kristjansdottir, H.
    Grondal, G.
    Erlendsson, K.
    Steinsson, K.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 14 - 14
  • [40] The PD-1 Interactome
    Wang, Qi
    Bardhan, Kankana
    Boussiotis, Vassiliki A.
    Patsoukis, Nikolaos
    ADVANCED BIOLOGY, 2021, 5 (09):
12345